Annual Accounts Payable
$10.87 M
+$3.90 M+56.03%
December 31, 2023
Summary
- As of February 7, 2025, BLRX annual accounts payable is $10.87 million, with the most recent change of +$3.90 million (+56.03%) on December 31, 2023.
- During the last 3 years, BLRX annual accounts payable has risen by +$4.95 million (+83.66%).
- BLRX annual accounts payable is now at all-time high.
Performance
BLRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.63 M
-$1.63 M-26.06%
September 1, 2024
Summary
- As of February 7, 2025, BLRX quarterly accounts payable is $4.63 million, with the most recent change of -$1.63 million (-26.06%) on September 1, 2024.
- Over the past year, BLRX quarterly accounts payable has dropped by -$3.81 million (-45.09%).
- BLRX quarterly accounts payable is now -57.37% below its all-time high of $10.87 million, reached on December 31, 2023.
Performance
BLRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BLRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.0% | -45.1% |
| 3 y3 years | +83.7% | -14.8% |
| 5 y5 years | +141.9% | -14.8% |
BLRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.2% | -57.4% | at low |
| 5 y | 5-year | at high | +95.2% | -57.4% | at low |
| alltime | all time | at high | +557.1% | -57.4% | +422.7% |
BioLineRx Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.63 M(-26.1%) |
| Jun 2024 | - | $6.27 M(-24.1%) |
| Mar 2024 | - | $8.26 M(-24.0%) |
| Dec 2023 | $10.87 M(+56.0%) | $10.87 M(+28.8%) |
| Sep 2023 | - | $8.44 M(+25.3%) |
| Jun 2023 | - | $6.73 M(-5.6%) |
| Mar 2023 | - | $7.14 M(+2.4%) |
| Dec 2022 | $6.97 M(+25.1%) | $6.97 M(+19.5%) |
| Sep 2022 | - | $5.83 M(-20.6%) |
| Jun 2022 | - | $7.34 M(+26.9%) |
| Mar 2022 | - | $5.78 M(+3.9%) |
| Dec 2021 | $5.57 M(-5.9%) | $5.57 M(+2.3%) |
| Sep 2021 | - | $5.44 M(+2.3%) |
| Jun 2021 | - | $5.32 M(-7.6%) |
| Mar 2021 | - | $5.76 M(-2.7%) |
| Dec 2020 | $5.92 M(-24.1%) | $5.92 M(-0.3%) |
| Sep 2020 | - | $5.93 M(-19.8%) |
| Jun 2020 | - | $7.40 M(-1.2%) |
| Mar 2020 | - | $7.49 M(-3.9%) |
| Dec 2019 | $7.79 M(+73.5%) | $7.79 M(+47.0%) |
| Sep 2019 | - | $5.30 M(+16.2%) |
| Jun 2019 | - | $4.57 M(-5.2%) |
| Mar 2019 | - | $4.82 M(+7.2%) |
| Dec 2018 | $4.49 M(-18.5%) | $4.49 M(+18.1%) |
| Sep 2018 | - | $3.80 M(-7.8%) |
| Jun 2018 | - | $4.13 M(-16.5%) |
| Mar 2018 | - | $4.94 M(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $5.52 M(+113.0%) | $5.52 M(+26.8%) |
| Sep 2017 | - | $4.35 M(+2.0%) |
| Jun 2017 | - | $4.26 M(+23.5%) |
| Mar 2017 | - | $3.45 M(+33.2%) |
| Dec 2016 | $2.59 M(+35.6%) | $2.59 M(+13.9%) |
| Sep 2016 | - | $2.27 M(+31.3%) |
| Jun 2016 | - | $1.73 M(+18.2%) |
| Mar 2016 | - | $1.47 M(-23.3%) |
| Dec 2015 | $1.91 M(+15.5%) | $1.91 M(-18.7%) |
| Sep 2015 | - | $2.35 M(-20.6%) |
| Jun 2015 | - | $2.96 M(+13.2%) |
| Mar 2015 | - | $2.61 M(+58.0%) |
| Dec 2014 | $1.65 M(-27.7%) | $1.65 M(+8.7%) |
| Sep 2014 | - | $1.52 M(-18.4%) |
| Jun 2014 | - | $1.86 M(-5.4%) |
| Mar 2014 | - | $1.97 M(-13.9%) |
| Dec 2013 | $2.29 M(-30.4%) | $2.29 M(-35.0%) |
| Sep 2013 | - | $3.52 M(-14.8%) |
| Jun 2013 | - | $4.13 M(-30.9%) |
| Mar 2013 | - | $5.99 M(+82.1%) |
| Dec 2012 | $3.29 M(+11.0%) | $3.29 M(+10.8%) |
| Sep 2012 | - | $2.97 M(+5.8%) |
| Jun 2012 | - | $2.81 M(-14.5%) |
| Mar 2012 | - | $3.28 M(+10.8%) |
| Dec 2011 | $2.96 M | $2.96 M(+99.9%) |
| Sep 2011 | - | $1.48 M(+17.7%) |
| Jun 2011 | - | $1.26 M(+42.1%) |
| Mar 2011 | - | $886.30 K |
FAQ
- What is BioLineRx annual accounts payable?
- What is the all time high annual accounts payable for BioLineRx?
- What is BioLineRx annual accounts payable year-on-year change?
- What is BioLineRx quarterly accounts payable?
- What is the all time high quarterly accounts payable for BioLineRx?
- What is BioLineRx quarterly accounts payable year-on-year change?
What is BioLineRx annual accounts payable?
The current annual accounts payable of BLRX is $10.87 M
What is the all time high annual accounts payable for BioLineRx?
BioLineRx all-time high annual accounts payable is $10.87 M
What is BioLineRx annual accounts payable year-on-year change?
Over the past year, BLRX annual accounts payable has changed by +$3.90 M (+56.03%)
What is BioLineRx quarterly accounts payable?
The current quarterly accounts payable of BLRX is $4.63 M
What is the all time high quarterly accounts payable for BioLineRx?
BioLineRx all-time high quarterly accounts payable is $10.87 M
What is BioLineRx quarterly accounts payable year-on-year change?
Over the past year, BLRX quarterly accounts payable has changed by -$3.81 M (-45.09%)